NeoGenomics, Inc.
Key Metrics
- Previous Close
- $15.25
- 52-Week Range
- $7.07 – $20.15
- Market Cap
- $1.98B
- P/E (TTM)
- —
- EPS (TTM)
- -0.24
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 2.47
- PEG Ratio
- 2.09
- Return on Equity
- -3.94%
- Return on Assets
- -1.96%
- Gross Margin
- 44.77%
- Operating Margin
- -5.47%
- Profit Margin
- -4.10%
- Current Ratio
- 3.53
- Debt/Equity
- 0.56
- Total Debt
- $449.14M
- Free Cash Flow
- $4.80M
- Revenue Growth
- 11.40%
- Earnings Growth
- —
- Enterprise Value
- $2.29B
Market Snapshot
About
NeoGenomics, Inc. provides cancer-focused genetic testing and diagnostics services. The company offers molecular and cytogenetic testing, pathology services, and clinical trials support to oncologists, hospitals, and pharmaceutical clients.